We are thrilled to share an important milestone for patients with pseudomyxoma peritonei (PMP). Dr. Kjersti Flatmark and her team at Oslo University Hospital have received approval from Norwegian regulatory authorities to begin a clinical trial of Pseudovax, a vaccine being developed as a potential new treatment for PMP. About the Pseudovax PMP vaccine trial Many PMP tumors carry a...